As of 2025-11-02, the Intrinsic Value of Spigen Korea Co Ltd (192440.KQ) is 36,969.45 KRW. This 192440.KQ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 22,300.00 KRW, the upside of Spigen Korea Co Ltd is 65.80%.
The range of the Intrinsic Value is 30,707.49 - 47,959.66 KRW
Based on its market price of 22,300.00 KRW and our intrinsic valuation, Spigen Korea Co Ltd (192440.KQ) is undervalued by 65.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 30,707.49 - 47,959.66 | 36,969.45 | 65.8% |
| DCF (Growth 10y) | 23,462.30 - 31,898.67 | 26,593.57 | 19.3% |
| DCF (EBITDA 5y) | 42,832.28 - 69,061.05 | 51,927.41 | 132.9% |
| DCF (EBITDA 10y) | 37,514.65 - 63,032.56 | 46,360.00 | 107.9% |
| Fair Value | 18,852.90 - 18,852.90 | 18,852.90 | -15.46% |
| P/E | 28,580.99 - 50,450.34 | 37,606.48 | 68.6% |
| EV/EBITDA | 24,674.87 - 79,916.40 | 47,460.72 | 112.8% |
| EPV | 10,100.57 - 12,512.58 | 11,306.58 | -49.3% |
| DDM - Stable | 24,112.78 - 54,386.44 | 39,249.68 | 76.0% |
| DDM - Multi | 35,722.68 - 65,165.00 | 46,374.12 | 108.0% |
| Market Cap (mil) | 138,706.00 |
| Beta | 0.64 |
| Outstanding shares (mil) | 6.22 |
| Enterprise Value (mil) | 105,323.20 |
| Market risk premium | 5.82% |
| Cost of Equity | 9.09% |
| Cost of Debt | 4.25% |
| WACC | 9.01% |